Furthermore, due to the biological activity of GSK-3β, we speculate that 9-butyl-harmol also has the potential to serve as a candidate for diabetes mellitus and Alzheimer’s disease. Here, GSK3B is linked to early-onset autosomal dominant Alzheimer disease.